Sirio Pharma Co., Ltd.

    Jurisdiction
    China
    ISIN
    CNE100003NB0 (300791.SZ)
    Sectors
    1. Consumer Defensive
    2. Packaged Foods

    Scores

    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    5 / 7

    Profile

    Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplements to customers worldwide. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €513.37M
    Gross margin
    32.0%
    EBIT
    €39.42M
    EBIT margin
    7.7%
    Net income
    €39.95M
    Net margin
    7.8%

    Statement period: - (published )

    Dividends

    Last dividend amount
    CN¥0.50
    Ex date
    Payment date
    Dividend payout ratio
    54.5%

    Add to watchlist

    Notifications